Business Wire

Enviva to Present at the Global Clean Energy Action Forum in Pittsburgh

Share

Today, Enviva Inc. (NYSE: EVA), the world’s leading producer of sustainably sourced woody biomass, announced that it will be presenting at the Global Clean Energy Action Forum on Thursday and Friday, September 22-23, 2022 in Pittsburgh, PA. Enviva’s President, Thomas Meth, will join an assembly of the world’s largest and leading companies, countries, and international experts who share the common mission of accelerating the clean energy transition.

“Today, woody biomass plays an important role in the global transition to a low-carbon economy – used predominately to decarbonize power and heat. At Enviva, we are proud that our product has been able to displace more than 48.3 million cumulative metric tons of CO2e since our inception nearly 20 years ago,” said Mr. Meth. “The future of our company is rapidly changing as utilization of woody biomass is expected to grow significantly by 2050 to help decarbonize hard-to-abate sectors. We couldn’t be more excited about all that modern bioenergy has to offer and about unlocking its full potential,” added Mr. Meth.

Of all global emitters, energy-intensive industries represent the hardest sectors to abate for net-zero, and the use of woody biomass feedstocks in these sectors creates new opportunities for decarbonization where urgent solutions are needed to reach climate targets. Recognizing this opportunity, Enviva is expanding its focus to include additional dynamic market opportunities — such as sustainable aviation fuel (SAF), green lime, green steel, and green cement — in addition to its core business of supplying the energy sector with a renewable, drop-in alternative to coal. Earlier this month, Enviva announced its partnership with Alder Fuels to scale and commercialize sustainable aviation fuel supply chains. This joint effort enables Enviva’s sourcing of sustainable wood fiber and Alder Fuels’ industry-leading technology to deliver the feedstock flexibility and commercialization of SAF needed to achieve jet fuel decarbonization at scale.

The 2022 Global Clean Energy Action Forumhas already attracted more than 5,000 delegates from governments, international organizations, industry, academia, innovators, and NGOs. The event will cover the entire cleantech spectrum via Ministerial plenaries, topical roundtables, and over 100 technology-specific events with CEOs and experts from around the world, as well as energy and science ministers from 31 countries, dedicated to accelerating the production and use of sustainable, low GHG-emissions fuels, chemicals, and materials.

To learn more on how Enviva is maximizing the use of woody biomass in heavy energy-intensive industries, we invite you to read our new white paper – Biomass: Unlocking a Future Beyond Fossil Fuelhere. To learn more about the Enviva and Alder Fuels partnership click here.

About Enviva

Enviva Inc. (NYSE: EVA) is the world’s largest producer of industrial wood pellets, a renewable and sustainable energy source produced by aggregating a natural resource, wood fiber, and processing it into a transportable form, wood pellets. Enviva owns and operates ten plants with a combined production capacity of approximately 6.2 million metric tons per year in Virginia, North Carolina, South Carolina, Georgia, Florida, and Mississippi, and is constructing its 11th plant in Epes, Alabama. Enviva sells most of its wood pellets through long-term, take-or-pay off-take contracts with creditworthy customers in the United Kingdom, the European Union, and Japan, helping to accelerate the energy transition and to decarbonize hard-to-abate sectors like steel, cement, lime, chemicals, and aviation fuels. Enviva exports its wood pellets to global markets through its deep-water marine terminals at the Port of Chesapeake, Virginia, the Port of Wilmington, North Carolina, and the Port of Pascagoula, Mississippi, and from third-party deep-water marine terminals in Savannah, Georgia, Mobile, Alabama, and Panama City, Florida.

To learn more about Enviva, please visit our website at www.envivabiomass.com. Follow Enviva on social media @Enviva.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

MEDIA:
Maria C. Moreno
Maria.Moreno@envivabiomass.com
+1 240-858-9321

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Neustar Security Services expands partner network in EMEA27.9.2022 14:00:00 CEST | Press release

Neustar Security Services, a leading provider of cloud-oriented security services that enable global businesses to thrive online, has expanded its partner ecosystem across key technology hubs in the Europe, Middle East and Africa region. The company’s new partners include CyberArm in Lebanon; Infinity IT in the Netherlands; Arcane BT in Turkey; Caretower, an Integrity 360 Company, in the U.K.; and K-Tel in Germany. The partner expansion is the latest in a series of milestones as Neustar Security Services evolves its business and industry-leading solutions across the EMEA region. The signing of CyberArm, the company’s first partner in the Middle East, coincides with the opening of a new data scrubbing center in Dubai, its 15th global node. The company continues to invest in increasing the capacity and resilience of its network, which now boasts more than 15 Terabits per second (Tbps) of total distributed-denial-of-service (DDoS) attack mitigation scrubbing capacity globally. “Partners a

Airship Details Speakers for Elevate22, a Global Gathering of Mobile-First CXOs and Business Decision-Makers27.9.2022 13:37:00 CEST | Press release

Mobile app experience company Airship today announced speakers for Elevate22: Mastering MAX, an annual global forum for business leaders striving to create exponential value for both customers and brands through mobile apps. After two years of virtual gatherings, Elevate22 will take place on September 28 in New York City at Glasshouse Chelsea and in London on October 13 at Shoreditch Studios. Brand speakers include executives from Accenture, Bauer Media Group, BBC, Chipper Cash, CNET, DAZN, Disneyland Paris, Forrester Research, Inc., France TV, KeyBank, Kindred Group, Kingfisher plc, NBC Sports, OLIO, PayByPhone, SiriusXM, Southwest Airlines, Studio, YES Network and Zillow Group. Elevate22 programming is designed to both inspire and share proven strategies across the entire mobile app customer lifecycle, from acquiring customers and rethinking how to optimize life after download™, to optimizing the long game and navigating the changing data environment. The event is curated for executi

Aktana and Envision Pharma Group Partner to Help Medical Affairs Navigate the Evolving Physician Engagement Landscape27.9.2022 13:33:00 CEST | Press release

Aktana, the leader in intelligent customer engagement for the life sciences industry, and Envision Pharma Group, a global, technology-enabled scientific communications company operating across many areas of medical affairs, announce a strategic partnership that provides medical teams with a comprehensive toolkit for more impactful scientific exchange. By bringing together their extensive technical and industry expertise, Envision and Aktana offer life science companies the ability to enable their medical science liaisons (MSLs) to address HCP demands for personalized, scientifically relevant content and coordinated omnichannel engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005291/en/ Despite the industry’s separation between commercial and medical teams, today’s HCPs expect MSLs to operate with a holistic view of their engagement with the product. While many life sciences companies have already started equi

FourKites Announces $10M Strategic Investment from Mitsui & Co. to Transform Supply Chains in Asia-Pacific27.9.2022 13:30:00 CEST | Press release

Leading supply chain visibility company FourKites today announces a $10M investment from Mitsui & Co., Ltd. to expand FourKites’ offerings across the APAC region. This investment encompasses the first phase in an ongoing strategic relationship between FourKites and Mitsui, which the two companies intend to formalise by the end of the year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005141/en/ FourKites Announces $10M Strategic Investment from Mitsui & Co. to Transform Supply Chains in Asia-Pacific (Graphic: Business Wire) Mitsui’s investment in FourKites is the culmination of a yearlong effort between the two companies, which included Mitsui’s extensive due diligence of the supply chain visibility landscape. Given FourKites’ market-leading offerings and proven track record in the region, Mitsui is planning to invest significant resources to expand FourKites’ coverage in APAC, including sales, customer service, oper

Forge Biologics Fuels Gene Therapy Manufacturing Engine with Launch of Plasmid DNA Manufacturing Services to Support AAV Clients27.9.2022 13:00:00 CEST | Press release

Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced the new availability of plasmid DNA manufacturing to its suite of scalable manufacturing services for gene therapy programs, complementing Forge’s existing AAV process development, analytical development, cGMP manufacturing, and automated final fill capabilities. Forge’s plasmid manufacturing services encompass three grades to accommodate a phase-appropriate approach: Research-Grade, suitable for discovery, research and development; GMP-Pathway, suitable for early-stage clinical trial cGMP AAV manufacturing, and cGMP, suitable for late-stage clinical and commercial cGMP manufacturing. Forge’s plasmid production services utilize single-use systems that seamlessly integrate into the Company’s platform AAV manufacturing process, allowing continuity of manufacturing for clients and streamlined vendor management. Research-Grade and GMP-Pathway plasmid grades are currently available,